PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-21.6%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.63B
AUM Growth
+$2.63B
Cap. Flow
-$167M
Cap. Flow %
-6.36%
Top 10 Hldgs %
51.5%
Holding
141
New
26
Increased
20
Reduced
29
Closed
42
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CLVS
126
DELISTED
Clovis Oncology, Inc.
CLVS
-150,000
Closed -$4.41M
PTE
127
DELISTED
PolarityTE, Inc. Common Stock
PTE
-336,818
Closed -$6.43M
ODT
128
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-100,000
Closed -$1.94M
ADMS
129
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
-422,015
Closed -$8.45M
ACHN
130
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
-1,000,000
Closed -$3.68M
NVTR
131
DELISTED
Nuvectra Corporation Common Stock
NVTR
-135,000
Closed -$2.97M
TSRO
132
DELISTED
TESARO, Inc.
TSRO
-200,000
Closed -$7.8M
ECYT
133
DELISTED
Endocyte, Inc. Common Stock
ECYT
-2,441,700
Closed -$43.4M
ONSIW
134
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
-420,875
Closed -$6K
CORI
135
DELISTED
Corium International, Inc.
CORI
-6,357,133
Closed -$60.5M
BHVN
136
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-990,943
Closed -$37.2M